期刊文献+

2例高血压患者个体化给药方案的合理性评价和干预 被引量:2

Rationality Evaluation and Intervention of Individualized Treatment Programs in 2 Cases of Hypertensive Patients
原文传递
导出
摘要 目的:探索高血压患者个体化治疗模式,实现血压达标和靶器官保护。方法:依据中国高血压防治指南2010,结合患者的病情和经济承受能力,评价治疗方案的合理性并进行干预。病例A采用了短效制剂,但根据患者具体经济情况和长期承受能力,选择了适合患者的降压药物,并且血压在逐渐趋于达标,体现了降压治疗的个体化原则;病例B依据该患者的血压控制情况和靶器官损害程度,并考虑经济承受能力,对整体治疗方案给予个体化的调整和用药指导,达到了理想的血压控制达标率,预防了亚临床靶器官损害和心脑血管事件的发生。结果与结论:合理评价和干预治疗方案,可提高患者的用药依从性,提高血压达标率以最大限度地降低致残率和致死率,提高患者的生活质量。 OBJECTIVE: To discuss the clinical thinking which focuses on drug therapy, and to summarize the experiences of pharmaceutical care. METHODS: Drug use in a patient with pulmonary infection treated with integrated traditional Chinese and western medicine therapy was analyzed by clinical pharmacist and anti-infective plan was evaluated according to principle for clinical use of antibiotics: for common pathogen, piperacillin/tazobactam combined with levofloxacin were given, and oral administration azithromycin replaced levofloxacin if the disease condition was improved; for antibiotics-related diarrhea, intravenous antibiotics was cancelled and metronidazole 0.4 g was given orally, tid; Bacillus licheniformis capsule and Bifid triple viable capsule were used to regulate intestinal flora, and fluconazol 200 mg was given orally as antifungal therapy; TCM was mainly used for regulating spleen and stomach, excreting dampness and stopping diarrhea. RESULTS: The pulmonary infection had been controlled and diarrhea was also improved. The patient received relevant treatment after discharging from the hospital. CONCLUSIONS: Western medicine is combined with TCM theory for disease diagnose can improve immunologic function and nutritional status so as to control the infection and reduce disease replase.
作者 赵智 何忠芳
出处 《中国药房》 CAS CSCD 2014年第22期2106-2108,共3页 China Pharmacy
关键词 高血压 个体化治疗 评价 干预 Integrated Chinese and western medicine Pulmonary infection Analysis of drug use Pharmaceutical care
  • 相关文献

参考文献9

  • 1刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-708. 被引量:6982
  • 2Liu L, Zhang Y, Liu G, et al. The Felodipine Event Re- duction (FEVER)Study: a randomized long-term place- bo-controlled trial in Chinese hypertensive patients[J]. J Hypertens, 2005,23 (12) : 2 157.
  • 3王文,张宇清,张学中,张善同,唐新华,陈涛,周景春,张亮清,张廷杰,孙明,王云献,齐德仁,王宪衍,刘力生.高血压患者治疗后平均血压水平与心脑血管事件的关系--非洛地平降低并发症研究分析[J].中华高血压杂志,2010,18(5):439-443. 被引量:28
  • 4Coyle D, Rodby R, Soroka S, et al. Cost-effectiveness oIirbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal dis- ease : a Canadian perspective[J]. Clin Ther, 2007,29 (7) : 1 508.
  • 5Park HC, Choi HY, Kim BS, et al. The effect of losartan in non-diabetic renal disease is not dependent on ACE in- sertion/deletion polymorphism[J]. Kidney Blood Press Res,2006,29(4) :216.
  • 6Wang JG, Kario K, Lau T, et al. Use of dihydropyridine calcium channel blockers in the management of hyperten- sion in Eastern Asians: a scientific statement from theAsian Pacific heart association[J]. Hypertens Res, 2011, 34(4) :423.
  • 7Wang JG, Li Y, Franklin SS, et al. Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview[J]. Hyperten- sion,2007,50 (1): 181.
  • 8Baigent C, Blackwell L, Collins R, et al. Aspirin in the pri- mary and secondary prevention of vascular disease: collab- orative meta analysis of individual participant data from randomised trials[J]. Lancet, 2009,373 (9 678 ) : 1 849.
  • 9Antithrombotic Trialists' Collaboration.Collaborative me- ta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [J]. BMJ, 2002,324 (7 329 ) : 71.

二级参考文献47

共引文献6999

同被引文献17

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部